The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis
Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID‐19 patients, we conducted a...
Gespeichert in:
| Veröffentlicht in: | Annals of the New York Academy of Sciences 2021-02, Vol.1486 (1), p.90-111 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 111 |
|---|---|
| container_issue | 1 |
| container_start_page | 90 |
| container_title | Annals of the New York Academy of Sciences |
| container_volume | 1486 |
| creator | Deng, Jiawen Zhou, Fangwen Hou, Wenteng Silver, Zachary Wong, Chi Yi Chang, Oswin Huang, Emma Zuo, Qi Kang |
| description | Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID‐19 patients, we conducted a systematic review and random‐effects meta‐analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37–54%, I2 = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37–57%, I2 = 97%), and the pooled prevalence of sleeping disturbances was 34% (95% CI: 19–50%, I2 = 98%). We did not find any significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools. More observational studies assessing the mental wellness of COVID‐19 outpatients and COVID‐19 patients from countries other than China are needed to further examine the psychological implications of COVID‐19 infections.
The objective of this systematic review and meta‐analysis was to assess the prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients. Our findings suggest that 45% of COVID‐19 patients experience depression, 47% of patients experience anxiety, and 34% of patients experience sleep disturbances. A majority of the included patients were inpatients and patients from China. We did not find any differences in prevalence between patients of different gender, however, the prevalence of depression and anxiety varied depending on the use of different screening tools. |
| doi_str_mv | 10.1111/nyas.14506 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7675607</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2448411824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5146-af9c669f7b57b92d32b43dd90539ee58a85e29393e3119bbbd9271e763b341983</originalsourceid><addsrcrecordid>eNp9kc1OFTEYhhuDgSOw8QJMEzbGONi_aacsTMgRlYTIQjRx1bQz30DJnM7YzqCz4xK8Rq_EHg8SdUE37dc-efI2L0JPKTmkeb0Ks02HVJREPkILqoQupORsCy0IUaqoNOM76ElK14RQVgm1jXY4J0RLWS3Q5cUV4CHCje0g1ID7FjeQ55R8H15iG757GOf1ocGpAxhw49M4RWcznbAPeHn--fTNz9sfVOPBjh7CmI6wxSsYbb61wXZz8mkPPW5tl2D_bt9Fn96eXCzfF2fn706Xx2dFXVIhC9vqWkrdKlcqp1nDmRO8aTQpuQYoK1uVwDTXHDil2jnXaKYoKMkdF1RXfBe93niHya2gqXOcaDszRL-ycTa99ebfl-CvzGV_Y5RUpSQqC57fCWL_dYI0mpVPNXSdDdBPyTAhKkFpxURGD_5Dr_sp5g-vKU0FV0KWmXqxoerYpxShvQ9DiVn3Z9b9md_9ZfjZ3_Hv0T-FZYBugG--g_kBlfnw5fjjRvoLzySnmQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2491437465</pqid></control><display><type>article</type><title>The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Deng, Jiawen ; Zhou, Fangwen ; Hou, Wenteng ; Silver, Zachary ; Wong, Chi Yi ; Chang, Oswin ; Huang, Emma ; Zuo, Qi Kang</creator><creatorcontrib>Deng, Jiawen ; Zhou, Fangwen ; Hou, Wenteng ; Silver, Zachary ; Wong, Chi Yi ; Chang, Oswin ; Huang, Emma ; Zuo, Qi Kang</creatorcontrib><description>Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID‐19 patients, we conducted a systematic review and random‐effects meta‐analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37–54%, I2 = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37–57%, I2 = 97%), and the pooled prevalence of sleeping disturbances was 34% (95% CI: 19–50%, I2 = 98%). We did not find any significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools. More observational studies assessing the mental wellness of COVID‐19 outpatients and COVID‐19 patients from countries other than China are needed to further examine the psychological implications of COVID‐19 infections.
The objective of this systematic review and meta‐analysis was to assess the prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients. Our findings suggest that 45% of COVID‐19 patients experience depression, 47% of patients experience anxiety, and 34% of patients experience sleep disturbances. A majority of the included patients were inpatients and patients from China. We did not find any differences in prevalence between patients of different gender, however, the prevalence of depression and anxiety varied depending on the use of different screening tools.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/nyas.14506</identifier><identifier>PMID: 33009668</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Anxiety ; Anxiety - epidemiology ; Anxiety - etiology ; coronavirus ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 - psychology ; depression ; Depression - epidemiology ; Depression - etiology ; Disturbances ; Female ; Health risks ; Humans ; Male ; Mental depression ; Mental disorders ; Mental Health ; Meta-analysis ; Original ; pandemic ; Pandemics ; Prevalence ; SARS-CoV-2 ; Sleep ; sleep disturbance ; Sleep Wake Disorders - epidemiology ; Sleep Wake Disorders - etiology ; Viral diseases ; Wellness</subject><ispartof>Annals of the New York Academy of Sciences, 2021-02, Vol.1486 (1), p.90-111</ispartof><rights>2020 New York Academy of Sciences.</rights><rights>2021 The New York Academy of Sciences</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5146-af9c669f7b57b92d32b43dd90539ee58a85e29393e3119bbbd9271e763b341983</citedby><cites>FETCH-LOGICAL-c5146-af9c669f7b57b92d32b43dd90539ee58a85e29393e3119bbbd9271e763b341983</cites><orcidid>0000-0002-3064-6182 ; 0000-0001-7363-546X ; 0000-0001-6236-764X ; 0000-0002-8491-4090 ; 0000-0002-8274-6468</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fnyas.14506$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fnyas.14506$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33009668$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deng, Jiawen</creatorcontrib><creatorcontrib>Zhou, Fangwen</creatorcontrib><creatorcontrib>Hou, Wenteng</creatorcontrib><creatorcontrib>Silver, Zachary</creatorcontrib><creatorcontrib>Wong, Chi Yi</creatorcontrib><creatorcontrib>Chang, Oswin</creatorcontrib><creatorcontrib>Huang, Emma</creatorcontrib><creatorcontrib>Zuo, Qi Kang</creatorcontrib><title>The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID‐19 patients, we conducted a systematic review and random‐effects meta‐analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37–54%, I2 = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37–57%, I2 = 97%), and the pooled prevalence of sleeping disturbances was 34% (95% CI: 19–50%, I2 = 98%). We did not find any significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools. More observational studies assessing the mental wellness of COVID‐19 outpatients and COVID‐19 patients from countries other than China are needed to further examine the psychological implications of COVID‐19 infections.
The objective of this systematic review and meta‐analysis was to assess the prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients. Our findings suggest that 45% of COVID‐19 patients experience depression, 47% of patients experience anxiety, and 34% of patients experience sleep disturbances. A majority of the included patients were inpatients and patients from China. We did not find any differences in prevalence between patients of different gender, however, the prevalence of depression and anxiety varied depending on the use of different screening tools.</description><subject>Anxiety</subject><subject>Anxiety - epidemiology</subject><subject>Anxiety - etiology</subject><subject>coronavirus</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - psychology</subject><subject>depression</subject><subject>Depression - epidemiology</subject><subject>Depression - etiology</subject><subject>Disturbances</subject><subject>Female</subject><subject>Health risks</subject><subject>Humans</subject><subject>Male</subject><subject>Mental depression</subject><subject>Mental disorders</subject><subject>Mental Health</subject><subject>Meta-analysis</subject><subject>Original</subject><subject>pandemic</subject><subject>Pandemics</subject><subject>Prevalence</subject><subject>SARS-CoV-2</subject><subject>Sleep</subject><subject>sleep disturbance</subject><subject>Sleep Wake Disorders - epidemiology</subject><subject>Sleep Wake Disorders - etiology</subject><subject>Viral diseases</subject><subject>Wellness</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1OFTEYhhuDgSOw8QJMEzbGONi_aacsTMgRlYTIQjRx1bQz30DJnM7YzqCz4xK8Rq_EHg8SdUE37dc-efI2L0JPKTmkeb0Ks02HVJREPkILqoQupORsCy0IUaqoNOM76ElK14RQVgm1jXY4J0RLWS3Q5cUV4CHCje0g1ID7FjeQ55R8H15iG757GOf1ocGpAxhw49M4RWcznbAPeHn--fTNz9sfVOPBjh7CmI6wxSsYbb61wXZz8mkPPW5tl2D_bt9Fn96eXCzfF2fn706Xx2dFXVIhC9vqWkrdKlcqp1nDmRO8aTQpuQYoK1uVwDTXHDil2jnXaKYoKMkdF1RXfBe93niHya2gqXOcaDszRL-ycTa99ebfl-CvzGV_Y5RUpSQqC57fCWL_dYI0mpVPNXSdDdBPyTAhKkFpxURGD_5Dr_sp5g-vKU0FV0KWmXqxoerYpxShvQ9DiVn3Z9b9md_9ZfjZ3_Hv0T-FZYBugG--g_kBlfnw5fjjRvoLzySnmQ</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Deng, Jiawen</creator><creator>Zhou, Fangwen</creator><creator>Hou, Wenteng</creator><creator>Silver, Zachary</creator><creator>Wong, Chi Yi</creator><creator>Chang, Oswin</creator><creator>Huang, Emma</creator><creator>Zuo, Qi Kang</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7ST</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3064-6182</orcidid><orcidid>https://orcid.org/0000-0001-7363-546X</orcidid><orcidid>https://orcid.org/0000-0001-6236-764X</orcidid><orcidid>https://orcid.org/0000-0002-8491-4090</orcidid><orcidid>https://orcid.org/0000-0002-8274-6468</orcidid></search><sort><creationdate>202102</creationdate><title>The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis</title><author>Deng, Jiawen ; Zhou, Fangwen ; Hou, Wenteng ; Silver, Zachary ; Wong, Chi Yi ; Chang, Oswin ; Huang, Emma ; Zuo, Qi Kang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5146-af9c669f7b57b92d32b43dd90539ee58a85e29393e3119bbbd9271e763b341983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anxiety</topic><topic>Anxiety - epidemiology</topic><topic>Anxiety - etiology</topic><topic>coronavirus</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - psychology</topic><topic>depression</topic><topic>Depression - epidemiology</topic><topic>Depression - etiology</topic><topic>Disturbances</topic><topic>Female</topic><topic>Health risks</topic><topic>Humans</topic><topic>Male</topic><topic>Mental depression</topic><topic>Mental disorders</topic><topic>Mental Health</topic><topic>Meta-analysis</topic><topic>Original</topic><topic>pandemic</topic><topic>Pandemics</topic><topic>Prevalence</topic><topic>SARS-CoV-2</topic><topic>Sleep</topic><topic>sleep disturbance</topic><topic>Sleep Wake Disorders - epidemiology</topic><topic>Sleep Wake Disorders - etiology</topic><topic>Viral diseases</topic><topic>Wellness</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deng, Jiawen</creatorcontrib><creatorcontrib>Zhou, Fangwen</creatorcontrib><creatorcontrib>Hou, Wenteng</creatorcontrib><creatorcontrib>Silver, Zachary</creatorcontrib><creatorcontrib>Wong, Chi Yi</creatorcontrib><creatorcontrib>Chang, Oswin</creatorcontrib><creatorcontrib>Huang, Emma</creatorcontrib><creatorcontrib>Zuo, Qi Kang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deng, Jiawen</au><au>Zhou, Fangwen</au><au>Hou, Wenteng</au><au>Silver, Zachary</au><au>Wong, Chi Yi</au><au>Chang, Oswin</au><au>Huang, Emma</au><au>Zuo, Qi Kang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>2021-02</date><risdate>2021</risdate><volume>1486</volume><issue>1</issue><spage>90</spage><epage>111</epage><pages>90-111</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID‐19 patients, we conducted a systematic review and random‐effects meta‐analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37–54%, I2 = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37–57%, I2 = 97%), and the pooled prevalence of sleeping disturbances was 34% (95% CI: 19–50%, I2 = 98%). We did not find any significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools. More observational studies assessing the mental wellness of COVID‐19 outpatients and COVID‐19 patients from countries other than China are needed to further examine the psychological implications of COVID‐19 infections.
The objective of this systematic review and meta‐analysis was to assess the prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients. Our findings suggest that 45% of COVID‐19 patients experience depression, 47% of patients experience anxiety, and 34% of patients experience sleep disturbances. A majority of the included patients were inpatients and patients from China. We did not find any differences in prevalence between patients of different gender, however, the prevalence of depression and anxiety varied depending on the use of different screening tools.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33009668</pmid><doi>10.1111/nyas.14506</doi><tpages>22</tpages><orcidid>https://orcid.org/0000-0002-3064-6182</orcidid><orcidid>https://orcid.org/0000-0001-7363-546X</orcidid><orcidid>https://orcid.org/0000-0001-6236-764X</orcidid><orcidid>https://orcid.org/0000-0002-8491-4090</orcidid><orcidid>https://orcid.org/0000-0002-8274-6468</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0077-8923 |
| ispartof | Annals of the New York Academy of Sciences, 2021-02, Vol.1486 (1), p.90-111 |
| issn | 0077-8923 1749-6632 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7675607 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Anxiety Anxiety - epidemiology Anxiety - etiology coronavirus Coronaviruses COVID-19 COVID-19 - complications COVID-19 - psychology depression Depression - epidemiology Depression - etiology Disturbances Female Health risks Humans Male Mental depression Mental disorders Mental Health Meta-analysis Original pandemic Pandemics Prevalence SARS-CoV-2 Sleep sleep disturbance Sleep Wake Disorders - epidemiology Sleep Wake Disorders - etiology Viral diseases Wellness |
| title | The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T19%3A22%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prevalence%20of%20depression,%20anxiety,%20and%20sleep%20disturbances%20in%20COVID%E2%80%9019%20patients:%20a%20meta%E2%80%90analysis&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Deng,%20Jiawen&rft.date=2021-02&rft.volume=1486&rft.issue=1&rft.spage=90&rft.epage=111&rft.pages=90-111&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1111/nyas.14506&rft_dat=%3Cproquest_pubme%3E2448411824%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2491437465&rft_id=info:pmid/33009668&rfr_iscdi=true |